Molecular advances in salivary gland pathology and their practical application

Diagnostic Histopathology

Volumn 18, Issue 9, 2012, Pages 388-396

  Skalova, Alena ^a   Vanecek, Tomas ^b   Simpson, Roderick H W ^c   Michal, Michal ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b Bioptic Laboratory   (Czech Republic)

^c ROYAL DEVON AND EXETER NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Adenoid cystic carcinoma; CRTC1 MAML2; ETV6 NTRK3; Mammary analogue secretory carcinoma; Mucoepidermoid carcinoma; MYB NFIB translocation; Salivary gland

Indexed keywords

CRTC1 PROTEIN; HYBRID PROTEIN; MAML2 PROTEIN; NFIB PROTEIN; NTRK3 PROTEIN; PROTEIN; PROTEIN MYB; TRANSCRIPTION FACTOR ETV6; UNCLASSIFIED DRUG;

ADENOID CYSTIC CARCINOMA; ADENOSQUAMOUS CARCINOMA; ARTICLE; CARCINOMA; CARCINOMA EX PLEOMORPHIC ADENOMA; CHROMOSOME TRANSLOCATION; FOLLOW UP; HUMAN; MAMMARY ANALOGUE SECRETORY CARCINOMA; MOLECULAR GENETICS; PROTEIN EXPRESSION; RARE DISEASE; SALIVARY GLAND CARCINOMA; SALIVARY GLAND DISEASE; SCLEROSING POLYCYSTIC ADENOSIS; TUMOR GROWTH;

EID: 84866744351     PISSN: 17562317     EISSN: 18767621     Source Type: Journal    
DOI: 10.1016/j.mpdhp.2012.08.002     Document Type: Article

References (53)

1. Simpson R.H.W., Di Palma S. Selected recent advances in the pathology of salivary neoplasm. Diagn Histopathology 2010, 16:276-286.
2. Skalova A., Vanecek T., Sima R., et al. Mammary analogue secretory carcinoma of salivary glands, containing the ETV6-NTRK3 fusion gene: a hitherto undescribed salivary gland tumor entity. Am J Surg Pathol 2010, 34:599-608.
3. Weinreb I., Simpson R.H., Skálová A., et al. Ductal adenomas of salivary glands showing features of striated duct differentiation (" striated duct adenoma" ) a report of six cases. Histopathology 2010, 57:707-715.
4. Skalova A., Sima R., Kaspirkova-Nemcova J., et al. Cribriform adenocarcinoma of minor salivary gland origin principally affecting the tongue: characterization of new entity. Am J Surg Pathol 2011, 35:1168-1176.
5. Hunt J.L. An update on molecular diagnostics of squamous and salivary gland tumors of the head and neck. Arch Pathol Lab Med 2011, 135:602-609.
6. Behboudi A., Enlund F., Winnes M., et al. Molecular classification of mucoepidermoid carcinomas-prognostic significance of the MECT1-MAML2 fusion oncogene. Genes Chromosomes Cancer 2006, 45:470-481.
7. Persson M., Andrén Y., Mark J., Horlings H.M., Persson F., Stenman G. Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neck. Proc Natl Acad Sci U S A 2009, 106:18740-18744.
8. Marchiò C., Weigelt B., Reis-Filho J.S. Adenoid cystic carcinomas of the breast and salivary glands (or 'The strange case of Dr Jekyll and Mr Hyde' of exocrine gland carcinomas). J Clin Pathol 2010, 63:220-228.
9. Stenman G. Fusion oncogenes and tumor type specificity-insights from salivary gland tumors. Semin Cancer Biol 2005, 15:224-235.
10. Skálová A., Gnepp D.R., Simpson R.H.W., et al. Clonal nature of sclerosing polycystic adenosis of salivary glands demonstrated by using the polymorphism of the human androgen receptor locus (HUMARA) as a marker. Am J Surg Pathol 2006, 30:939-944.
11. Di Palma S, Simpson RHW, Skalova A, et al. Salivary duct carcinoma can be classified into luminal/molecular apocrine, HER2 and basal-like phenotypes. Histopathology http://dx.doi.org/10.1111/j.1365-2559.2012.04252.x.
12. Skalova A., Sima R., Vanecek T., et al. Acinic cell carcinoma with high-grade transformation. Am J Surg Pathol 2009, 33:1137-1145.
13. El-Naggar A.K., Callender D., Coombes M.M., Hurr K., Luna M.A., Batsakis J.G. Molecular genetic alterations in carcinoma ex-pleomorphic adenoma: a putative progression model?. Genes Chromosomes Cancer 2000, 27:162-168.
14. Fowler M.H., Fowler J., Ducatman B., Barnes L., Hunt J.L. Malignant mixed tumors of the salivary gland: a study of loss of heterozygosity in tumor suppressor genes. Mod Pathol 2006, 19:350-355.
15. Goode R.K., El-Naggar A.K. Mucoepidermoid carcinoma. World Health Organization classification of tumours 2005, 219-220. IARC Press, Lyon. L. Barnes, J. Eveson, P. Reichart, D. Sidransky (Eds.).
16. Okabe M., Miyabe S., Nagatsuka H., et al. MECT1-MAML2 fusion transcript defines a favorable subset of mucoepidermoid carcinoma. Clin Cancer Res 2006, 12:3902-3907.
17. Seethala R.R., Dacic S., Cieply K., Kelly L.M., Nikiforova M.N. A reappraisal of the MECT1/MAML2 translocation in salivary mucoepidermoid carcinomas. Am J Surg Pathol 2010, 34:1106-1121.
18. Fehr A., Röser K., Heidorn K., Hallas C., Löning T., Bullerdiek J. A new type of MAML2 fusion in mucoepidermoid carcinoma. Genes Chromosomes Cancer 2008, 47:203-206.
19. Nakayama T., Miyabe S., Okabe M., et al. Clinicopathological significance of the CRTC3-MAML2 fusion transcript in mucoepidermoid carcinoma. Mod Pathol 2009, 22:1575-1581.
20. Okumura Y., Miyabe S., Nakayama T., et al. Impact of CRTC1/03-MAML2 fusions on histological classification and prognosis of mucoepidermoid carcinoma. Histopathology 2011, 59:90-97.
21. Moller E., Stenman G., Mandahl N., et al. POU5FI, encoding a key regulator of stem cell pluripotency, is fused to EWSRI in hidradenoma of the skin and mucoepidermoid carcinoma of the salivary glands. J Pathol 2008, 215:78-86.
22. El-Naggar A.K., Huvos A.G. Adenoid cystic carcinoma. World Health Organization classification of tumours 2005, 221-222. IARC Press, Lyon. L. Barnes, J. Eveson, P. Reichart, D. Sidransky (Eds.).
23. West R.B., Kong C., Clarke N., et al. MYB expression and translocation in adenoid cystic carcinomas and other salivary gland tumors with clinicopathologic correlation. Am J Surg Pathol 2011, 35:92-99.
24. Fehr A., Loning T., Stenman G. Mammary analogue secretory carcinoma of the salivary glands with ETV6-NTRK3 gene fusion. Am J Surg Pathol 2011, 35:1600-1602. Letter to Editor.
25. Lei Y., Chiosea S.I. Re-evaluating historic cohort of salivary acinic cell carcinoma with new diagnostic tools. Head and Neck Pathol 2012, 6:166-170.
26. Griffith C., Seethala R., Chiosea S.I. Mammary analogue secretory carcinoma: a new twist to the diagnostic dilemma of zymogen granule poor acinic cell carcinoma. Virchows Archiv 2011, 459:117-118.
27. Petersson F., Lian D., Chau Y.P., Yan B. Mammary analogue secretory carcinoma: the first submandibular case reported including findings on fine needle aspiration cytology. Head and Neck Pathol 2012, 6:135-139.
28. Ito S., Ishida E., Skalova A., Matsuura K., Kumamoto H., Sato I. Short communication: a case of mammary analogue secretory carcinoma of parotid gland. Pathol Int 2012, 62:149-152.
29. Chiosea S.I., Griffith C., Assad A., Seethala R.R. The profile of acinic cell carcinoma after recognition of mammary analog secretory carcinoma. Am J Surg Pathol 2012, 36:343-350.
30. Smith B.C., Ellis G.L., Slater L.J., et al. Sclerosing polycystic adenosis of major salivary glands: a clinicopathologic analysis of nine cases. Am J Surg Pathol 1996, 20:161-170.
31. Skalova A., Michal M., Simpson R.H.W., et al. Sclerosing polycystic adenosis of parotid gland with dysplasia and ductal carcinoma in situ: report of three cases with immunohistochemical and ultrastructural examination. Virchows Arch 2002, 440:29-35.
32. Petersson F., Tan P.H., Hwang J.S.G. Sclerosing polycystic adenosis of parotid gland: report of a bifocal, paucicystic variant with ductal carcinoma in situ and pronounced stromal distortion mimicking stromal invasion. Head Neck Pathol 2011, 5:188-192.
33. Kleinsasser O., Klein H.H., Hübner G. Speichelgangcarcinom: ein den milchgangcarcinomen der brüstdruse analoge gruppe von speicheldrüsentumoren. Archiv Für Klin Exper Ohren Nasen Kehlkopfheilkunde 1968, 192:100-115.
34. Brandwein-Gensler M.S., Skálová A., Nagao T. Salivary duct carcinoma. Pathology and genetics of head and neck tumours 2005, 236-237. IARC Press, Lyon. L. Barnes, J.W. Eveson, P. Reichart, D. Sidransky (Eds.).
35. Perou C.M., Sorlie T., Eisen M.B., et al. Molecular portraits of human breast tumours. Nature 2000, 406:747-752.
36. Nielsen T.O., Hsu F.D., Jensen K., et al. Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. Clin Cancer Res 2004, 10:5367-5374.
37. Williams M.D., Roberts D., Blumenschein G.R., et al. Differential expression of hormonal and growth factor receptors in salivary duct carcinomas: biologic significance and potential role in therapeutic stratification of patients. Am J Surg Pathol 2007, 31:1645-1652.
38. Cerilli L.A., Swartzbaugh J.R., Saadut R., et al. Analysis of chromosome 9p21 deletion and p16 gene mutation in salivary gland carcinomas. Hum Pathol 1999, 30:1242-1246.
39. Skálová A., Stárek I., Vaněček T., et al. Expression of HER-2/neu gene and protein in salivary duct carcinoma of parotid gland as revealed by fluorescence in-situ hybridization and immunohistochemistry. Histopathology 2003, 42:348-356.
40. Williams M.D., Roberts D.B., Kies M.S., Mao L., Weber R.S., El-Naggar A.K. Genetic and expression analysis of HER-2 and EGFR genes in salivary duct carcinoma: empirical and therapeutic significance. Clin Cancer Res 2010, 16:2266-2274.
41. Seethala R.R., Hunt J.L., Baloch Z.W., LiVolsi V.A., Barnes E.L. Adenoid cystic carcinoma with high-grade transformation. A report of 11 case and review of the literature. Am J Surg Pathol 2007, 31:1683-1694.
42. Simpson R.H.W., Reis-Filho J.S., Pereira E.M., et al. Polymorphous low-grade adenocarcinoma of the salivary glands with transformation to high-grade carcinoma. Histopathology 2002, 41:250-259.
43. Nagao T., Gaffey T.A., Kay P.A., et al. Dedifferentiation in low-grade mucoepidermoid carcinoma of the parotid gland. Hum Pathol 2003, 34:1068-1072.
44. Boyle J.O., Hakim J., Koch W., et al. The incidence of p53 mutations inc-reases with progression of head and neck cancer. Cancer Res 1993, 53:4477-4480.
45. Yamamoto Y., Virmani A.K., Wistuba, et al. Loss of heterozygosity and microsatellite alterations in p53 and RB genes in adenoid cystic carcinoma of the salivary glands. Hum Pathol 1996, 27:1204-1210.
46. Seethala R.R., Barnes E.L., Hunt J.L. Epithelial-myoepithelial carcinoma: a review of the clinicopathologic spectrum and immunophenotypic characteristics in 61 tumors of the salivary glands and aerodigestive tract. Am J Surg Pathol 2007, 31:44-57.
47. Röijer E., Nordkvist A., Ström A.K., et al. Translocation, deletion/amplification, and expression of HMGIC and MDM2 in a carcinoma ex pleomorphic adenoma. Am J Pathol 2002, 160:433-440.
48. Martins C., Fonseca I., Roque L., et al. PLAG1 gene alterations in salivary gland pleomorphic adenoma and carcinoma ex-pleomorphic adenoma: a combined study using chromosome banding, in situ hybridization and immunocytochemistry. Mod Pathol 2005, 18:1048-1055.
49. Rao P.H., Murty V.V., Louie D.C., Chaganti R.S. Nonsyntenic amplification of MYC with CDK4 and MDM2 in a malignant mixed tumor of salivary gland. Cancer Genet Cytogenet 1998, 105:160-163.
50. Persson F., Andrén Y., Winnes M., et al. High-resolution genomic profiling of adenomas and carcinomas of the salivary glands reveals amplification, rearrangement, and fusion of HMGA2. Genes Chromosomes Cancer 2009, 48:69-82.
51. Nordkvist A., Röijer E., Bang G., et al. Expression and mutation patterns of p53 in benign and malignant salivary gland tumors. Int J Oncol 2000, 16:477-483.
52. Gedlicka C., Item C.B., Wögerbauer M., et al. Transformation of pleomorphic adenoma to carcinoma ex pleomorphic adenoma of the parotid gland is independent of p53 mutations. J Surg Oncol 2010, 101:127-130.
53. Garcia J.J., Hunt J.L., Weinreb I., et al. Fluorescence in situ hybridization for detection of MAML2 rearrangements in oncocytic mucoepidermoid carcinomas: utility as a diagnostic test. Hum Pathol 2011, 42:2001-2009.